Cargando…
Increased activity of CHK enhances the radioresistance of MCF-7 breast cancer stem cells
The resistance of breast cancer to radiotherapy remains a major obstacle to successful cancer management. Radiotherapy may result in DNA damage and activate breast cancer stem cells. DNA damage may lead to activation of the checkpoint kinase (CHK) signaling pathway, of which debromohymenialdisine (D...
Autores principales: | YANG, ZHI-XUE, SUN, YI-HUI, HE, JIAN-GANG, CAO, HUA, JIANG, GUO-QIN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665200/ https://www.ncbi.nlm.nih.gov/pubmed/26788148 http://dx.doi.org/10.3892/ol.2015.3777 |
Ejemplares similares
-
Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cells
por: LIU, ZHI-GANG, et al.
Publicado: (2011) -
Enhanced radiation response in radioresistant MCF-7 cells by targeting peroxiredoxin II
por: Diaz, Anthony Joseph Gomez, et al.
Publicado: (2013) -
Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress
por: Zhang, Yao, et al.
Publicado: (2016) -
Profiling Global Kinome Signatures
of the Radioresistant
MCF-7/C6 Breast Cancer Cells Using MRM-based Targeted Proteomics
por: Guo, Lei, et al.
Publicado: (2014) -
Kinase-independent role for CRAF-driving tumour radioresistance via CHK2
por: Advani, Sunil J., et al.
Publicado: (2015)